[Ketotifen in allergic rhinitis].
Double-blind experiment (at random) comparative of the efficacy of ketotifen and Clemastina, for the treatment of periodic allergic Rhinitis. The study embraced 40 patients (21 men and 19 women) between 13 and 57 years old. The program was conducted on a fifty-fifty shares between both drugs. The clinic efficacy of ketotifen has been proved either as regards to clinic improvement or the less good results attained with the use of clemastine. The AA. guess on the prophylactic influence of ketotifen in asthmatic bronchial crisis among patients suffering allergic rhinitis.
Kaiser
C
C
Bernáldez
R
R
Moñux
A
A
Calatayud
J
J
D000293:Adolescent; D000328:Adult; D002974:Clemastine / Q000627:therapeutic use; D004311:Double-Blind Method; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007665:Ketotifen / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D002974:Clemastine; D007665:Ketotifen
El ketotifeno en las rinitis alérgicas.